Research & Literature
Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.
Top Authors
Top Institutions
Finding nearby institutions...
Mayo Clinic
Rochester, United States
University of Pennsylvania
Philadelphia, United States
Hôpital Cochin
Paris, France
GlaxoSmithKline (United States)
Philadelphia, United States
Cleveland Clinic
Cleveland, United States
Université Libre de Bruxelles
Brussels, Belgium
University of Utah
Salt Lake City, United States
Inserm
Paris, France
Hospital Clínic de Barcelona
Barcelona, Spain
National Institutes of Health
Bethesda, United States
References
References (105)
- 1
Eosinophilic myocarditis: case series and literature review.
Sohn KH, Song WJ, Kim BK, et al.
Asia Pacific allergy 2015; (5(2)):123-7 doi:10.5415/apallergy.2015.5.2.123.
PMID: 25938077 - 2
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management.
Groh M, Pagnoux C, Baldini C, et al.
European journal of internal medicine 2015; (26(7)):545-53.
PMID: 25971154 - 3
KIT D816V and JAK2 V617F mutations are seen recurrently in hypereosinophilia of unknown significance.
Schwaab J, Umbach R, Metzgeroth G, et al.
American journal of hematology 2015; (90(9)):774-7 doi:10.1002/ajh.24075.
PMID: 26017288 - 4
[Cardiac involvement in Churg-Strauss syndrome].
Brucato A, Maestroni S, Masciocco G, et al.
Giornale italiano di cardiologia (2006) 2015; (16(9)):493-500 doi:10.1714/1988.21524.
PMID: 26418389 - 5
Hypereosinophilic syndrome: cardiac diagnosis and management.
Mankad R, Bonnichsen C, Mankad S
Heart (British Cardiac Society) 2016; (102(2)):100-6 doi:10.1136/heartjnl-2015-307959.
PMID: 26567231 - 6
Pulmonary embolism, deep vein thrombosis and recurrent bone cysts in a patient with hypereosinophilic syndrome.
Chen TS, Xing LH, Wang SL, et al.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2016; (27(7)):831-834 doi:10.1097/MBC.0000000000000501.
PMID: 26780165 - 7
Clinical features predict responsiveness to imatinib in platelet-derived growth factor receptor-alpha-negative hypereosinophilic syndrome.
Khoury P, Desmond R, Pabon A, et al.
Allergy 2016; (71(6)):803-10 doi:10.1111/all.12843.
PMID: 26797802 - 8
[Hypereosinophilic syndrome with first presentation of pulmonary embolism and extensive venous thrombosis: a case report and literature review].
Xu W, Guo W, Yang T
Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 2015; (38(12)):912-7.
PMID: 26850893 - 9
Severe Prolonged Cough as Presenting Manifestation of FIP1L1-PDGFRA+ Chronic Eosinophilic Leukaemia: A Widely Ignored Association.
Roufosse F, Heimann P, Lambert F, et al.
Respiration; international review of thoracic diseases 2016; (91(5)):374-9 doi:10.1159/000446076.
PMID: 27164940 - 10
Blood and Bone Marrow Evaluation for Eosinophilia.
Boyer DF
Archives of pathology & laboratory medicine 2016; (140(10)):1060-7 doi:10.5858/arpa.2016-0223-RA.
PMID: 27684977 - 11
Hypereosinophilic syndrome.
Noh HR, Magpantay GG
Allergy and asthma proceedings 2017; (38(1)):78-81 doi:10.2500/aap.2017.38.3995.
PMID: 28052805 - 12
Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified and reactive idiopathic hypereosinophilic syndrome.
Wang SA, Hasserjian RP, Tam W, et al.
Haematologica 2017; (102(8)):1352-1360 doi:10.3324/haematol.2017.165340.
PMID: 28495918 - 13
Neutrophil-derived S100 calcium-binding proteins A8/A9 promote reticulated thrombocytosis and atherogenesis in diabetes.
Kraakman MJ, Lee MK, Al-Sharea A, et al.
The Journal of clinical investigation 2017; (127(6)):2133-2147.
PMID: 28504650 - 14
Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis.
Wechsler ME, Akuthota P, Jayne D, et al.
The New England journal of medicine 2017; (376(20)):1921-1932 doi:10.1056/NEJMoa1702079.
PMID: 28514601 - 15
Eosinophilic myocarditis and hypereosinophilic syndrome.
Boussir H, Ghalem A, Ismaili N, El Ouafi N
Journal of the Saudi Heart Association 2017; (29(3)):211-213 doi:10.1016/j.jsha.2016.11.001.
PMID: 28652675 - 16
Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis.
Thiel J, Troilo A, Salzer U, et al.
The journal of allergy and clinical immunology. In practice 2017; (5(6)):1556-1563 doi:10.1016/j.jaip.2017.07.027.
PMID: 28916432 - 17
Eosinophilic Myocarditis.
Cheung CC, Constantine M, Ahmadi A, et al.
The American journal of the medical sciences 2017; (354(5)):486-492 doi:10.1016/j.amjms.2017.04.002.
PMID: 29173361 - 18
Imatinib for the treatment of hypereosinophilic syndromes.
Helbig G
Expert review of clinical immunology 2018; (14(2)):163-170 doi:10.1080/1744666X.2018.1425142.
PMID: 29303368 - 19
Eosinophil-Related Disease and the Skin.
Leiferman KM, Peters MS
The journal of allergy and clinical immunology. In practice 2018; (6(5)):1462-1482.e6 doi:10.1016/j.jaip.2018.06.002.
PMID: 29902530 - 20
An Approach to the Evaluation of Persistent Hypereosinophilia in Pediatric Patients.
Schwartz JT, Fulkerson PC
Frontiers in immunology 2018; (9()):1944 doi:10.3389/fimmu.2018.01944.
PMID: 30233571 - 21
Acute pulmonary embolism and deep vein thrombosis secondary to idiopathic hypereosinophilic syndrome.
Li D, Xu L, Lin D, et al.
Respiratory medicine case reports 2018; (25()):213-215 doi:10.1016/j.rmcr.2018.09.006.
PMID: 30237972 - 22
Thrombosis in the portal venous system caused by hypereosinophilic syndrome: A case report.
Lin J, Huang X, Zhou W, et al.
Medicine 2018; (97(48)):e13425 doi:10.1097/MD.0000000000013425.
PMID: 30508952 - 23
Reactive thrombocytosis in acute infectious diseases: Prevalence, characteristics and timing.
Schattner A, Kadi J, Dubin I
European journal of internal medicine 2019; (63()):42-45 doi:10.1016/j.ejim.2019.02.010.
PMID: 30795883 - 24
Idiopathic Hypereosinophilic Syndrome in an Elderly Female: A Case Report.
Khalid F, Holguin F
The American journal of case reports 2019; (20()):381-384 doi:10.12659/AJCR.912747.
PMID: 30902963 - 25
Non-severe eosinophilic granulomatosis with polyangiitis: long-term outcomes after remission-induction trial.
Puéchal X, Pagnoux C, Baron G, et al.
Rheumatology (Oxford, England) 2019; (58(12)):2107-2116 doi:10.1093/rheumatology/kez139.
PMID: 31056661 - 26
A case of eosinophilic granulomatosis with polyangiitis complicated with a similar condition to IgG4 related lung disease.
Zhou L, Cao F, Fan S, et al.
BMC pulmonary medicine 2019; (19(1)):154 doi:10.1186/s12890-019-0917-4.
PMID: 31426769 - 27
Practical Approach to Children Presenting with Eosinophila and Hypereosinophilia.
Costagliola G, Marco SD, Comberiati P, et al.
Current pediatric reviews 2020; (16(2)):81-88 doi:10.2174/1573396315666191114150438.
PMID: 31729944 - 28
Causes of hypereosinophilia in 100 consecutive patients.
Moller D, Tan J, Gauiran DTV, et al.
European journal of haematology 2020; (105(3)):292-301 doi:10.1111/ejh.13437.
PMID: 32364630 - 29
Hypereosinophilia with Concurrent Venous Thromboembolism: Clinical Features, Potential Risk Factors, and Short-term Outcomes in a Chinese Cohort.
Liu Y, Meng X, Feng J, et al.
Scientific reports 2020; (10(1)):8359 doi:10.1038/s41598-020-65128-4.
PMID: 32433573 - 30
International Consensus on Antineutrophil Cytoplasm Antibodies Testing in Eosinophilic Granulomatosis with Polyangiitis.
Moiseev S, Bossuyt X, Arimura Y, et al.
American journal of respiratory and critical care medicine 2020; (202(10)):1360-1372 doi:10.1164/rccm.202005-1628SO.
PMID: 32584187 - 31
Mepolizumab as Possible Treatment for Allergic Bronchopulmonary Aspergillosis: A Review of Eight Cases.
Tolebeyan A, Mohammadi O, Vaezi Z, Amini A
Cureus 2020; (12(8)):e9684 doi:10.7759/cureus.9684.
PMID: 32923277 - 32
Efficacy and safety of mepolizumab in hypereosinophilic syndrome: A phase III, randomized, placebo-controlled trial.
Roufosse F, Kahn JE, Rothenberg ME, et al.
The Journal of allergy and clinical immunology 2020; (146(6)):1397-1405 doi:10.1016/j.jaci.2020.08.037.
PMID: 32956756 - 33
Loeffler's Endocarditis: An Integrated Multimodality Approach.
Polito MV, Hagendorff A, Citro R, et al.
Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 2020; (33(12)):1427-1441 doi:10.1016/j.echo.2020.09.002.
PMID: 33129649 - 34
Experimental Modeling of Eosinophil-Associated Diseases.
Upparahalli Venkateshaiah S, Manohar M, Kandikattu HK, Mishra A
Methods in molecular biology (Clifton, N.J.) 2021; (2241()):275-291 doi:10.1007/978-1-0716-1095-4_21.
PMID: 33486743 - 35
A case of hypereosinophilic syndrome with STAT5b N642H mutation.
Ding F, Wu C, Li Y, et al.
Oxford medical case reports 2021; (2021(1)):omaa129 doi:10.1093/omcr/omaa129.
PMID: 33542831 - 36
Venous thrombosis and predictors of relapse in eosinophil-related diseases.
Réau V, Vallée A, Terrier B, et al.
Scientific reports 2021; (11(1)):6388 doi:10.1038/s41598-021-85852-9.
PMID: 33737704 - 37
Eosinophil ETosis-Mediated Release of Galectin-10 in Eosinophilic Granulomatosis With Polyangiitis.
Fukuchi M, Kamide Y, Ueki S, et al.
Arthritis & rheumatology (Hoboken, N.J.) 2021; (73(9)):1683-1693 doi:10.1002/art.41727.
PMID: 33750029 - 38
Clinical Manifestations and Long-Term Outcomes of Eosinophilic Granulomatosis With Polyangiitis in North America.
Doubelt I, Cuthbertson D, Carette S, et al.
ACR open rheumatology 2021; (3(6)):404-412 doi:10.1002/acr2.11263.
PMID: 34032390 - 39
Eosinophils and eosinophil-associated disorders: immunological, clinical, and molecular complexity.
Valent P, Degenfeld-Schonburg L, Sadovnik I, et al.
Seminars in immunopathology 2021; (43(3)):423-438 doi:10.1007/s00281-021-00863-y.
PMID: 34052871 - 40
Hypereosinophilic syndrome: considerations for the cardiologist.
Bondue A, Carpentier C, Roufosse F
Heart (British Cardiac Society) 2022; (108(3)):164-171 doi:10.1136/heartjnl-2020-317202.
PMID: 34172539 - 41
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Chung SA, Langford CA, Maz M, et al.
Arthritis & rheumatology (Hoboken, N.J.) 2021; (73(8)):1366-1383 doi:10.1002/art.41773.
PMID: 34235894 - 42
Normalization of left ventricular filling pressure after cardiac surgery for the Loeffler's endocarditis: a case report.
Carcaterra A, Mock S, Müller H, Testuz A
European heart journal. Case reports 2021; (5(6)):ytab189 doi:10.1093/ehjcr/ytab189.
PMID: 34263118 - 43
Association of Thrombosis With Hypereosinophilic Syndrome in Patients With Genetic Alterations.
Leiva O, Baker O, Jenkins A, et al.
JAMA network open 2021; (4(8)):e2119812 doi:10.1001/jamanetworkopen.2021.19812.
PMID: 34357393 - 44
World Health Organization-defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management.
Shomali W, Gotlib J
American journal of hematology 2022; (97(1)):129-148 doi:10.1002/ajh.26352.
PMID: 34533850 - 45
Mepolizumab and dupilumab as a replacement to systemic glucocorticoids for the treatment of Chronic Eosinophilic Pneumonia and Allergic Bronchopulmonary Aspergillosis - Case series, Almoosa specialist hospital.
Eldaabossi SAM, Awad A, Anshasi N
Respiratory medicine case reports 2021; (34()):101520 doi:10.1016/j.rmcr.2021.101520.
PMID: 34692397 - 46
Literature reviews of stroke with hypereosinophilic syndrome.
Ono R, Iwahana T, Kato H, et al.
International journal of cardiology. Heart & vasculature 2021; (37()):100915 doi:10.1016/j.ijcha.2021.100915.
PMID: 34888412 - 47
2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis With Polyangiitis.
Grayson PC, Ponte C, Suppiah R, et al.
Arthritis & rheumatology (Hoboken, N.J.) 2022; (74(3)):386-392 doi:10.1002/art.41982.
PMID: 35106968 - 48
Eosinophilic granulomatosis with polyangiitis exhibits T cell activation and IgG4 immune response in the tissue; comparison with IgG4-related disease.
Kubo S, Kanda R, Nawata A, et al.
RMD open 2022; (8(1)) doi:10.1136/rmdopen-2021-002086.
PMID: 35260476 - 49
[Ten questions about eosinophilic myocarditis].
Pagura L, Imazio M, Merlo M, Sinagra G
Giornale italiano di cardiologia (2006) 2022; (23(4)):259-267 doi:10.1714/3766.37535.
PMID: 35343477 - 50
Association Between Baseline Therapy and Flare Reduction in Mepolizumab-Treated Patients With Hypereosinophilic Syndrome.
Reiter A, Lefevre G, Cid MC, et al.
Frontiers in immunology 2022; (13()):840974 doi:10.3389/fimmu.2022.840974.
PMID: 35493455 - 51
Rare Case of a Young Male Presented with Abdominal Pain, Solid Colon Tumors, and Eosinophilia, Followed by Tremendous Thromboembolic Complications and Eventually Diagnosed with Idiopathic Hypereosinophilic Syndrome.
Zemleduch T, Czapla A, Kimla P, Kudliński B
Case reports in medicine 2022; (2022()):1424749 doi:10.1155/2022/1424749.
PMID: 35646123 - 52
Portal Vein Thrombosis as a Cause of Undetermined Thrombocytopenia with Liver Dysfunction in a Patient with Eosinophilic Granulomatosis with Polyangiitis.
Oka N, Yoshida Y, Sugimoto T, et al.
Internal medicine (Tokyo, Japan) 2023; (62(1)):123-127 doi:10.2169/internalmedicine.9485-22.
PMID: 35705273 - 53
2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19.
Farge D, Frere C, Connors JM, et al.
The Lancet. Oncology 2022; (23(7)):e334-e347 doi:10.1016/S1470-2045(22)00160-7.
PMID: 35772465 - 54
Biologic therapies for hypereosinophilic disorders: From tyrosine kinase inhibitors to monoclonal antibodies. Towards an increasingly customized management?
Iurlo A, Cattaneo D
Blood reviews 2023; (58()):101014 doi:10.1016/j.blre.2022.101014.
PMID: 36153195 - 55
[ACUTE VISION LOSS ASSOCIATED WITH HYPEREOSINOPHILIC SYNDROME].
Man Peles I, Goldenberg-Cohen N
Harefuah 2022; (161(10)):603-605.
PMID: 36315204 - 56
Case Report: Pediatric myeloid/lymphoid neoplasm with eosinophilia and PDGFRA rearrangement: The first case presenting as B-lymphoblastic lymphoma.
Akiely R, Almasri F, Almasri N, Abu-Ghosh A
Frontiers in pediatrics 2022; (10()):1059527 doi:10.3389/fped.2022.1059527.
PMID: 36589160 - 57
Diagnostic spectrum of hypereosinophilia based on bone marrow pathology: 10 years' experience at a tertiary care hospital.
Kim H, Cho YU
International journal of laboratory hematology 2023; (45(3)):328-336 doi:10.1111/ijlh.14025.
PMID: 36756990 - 58
Acute Myeloid Leukaemia With Translocation (8;21) Masquerading as Peripheral Blood Eosinophilia Having Dysplastic Features: A Diagnostic Challenge.
Singh A, Tripathi T, Singh A, et al.
Cureus 2023; (15(1)):e33858 doi:10.7759/cureus.33858.
PMID: 36819451 - 59
EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update.
Hellmich B, Sanchez-Alamo B, Schirmer JH, et al.
Annals of the rheumatic diseases 2024; (83(1)):30-47 doi:10.1136/ard-2022-223764.
PMID: 36927642 - 60
[Eosinophilia: hypereosinophilic syndrome vs. eosinophilic granulomatosis with polyangiitis].
Holle JU, Moosig F
Zeitschrift fur Rheumatologie 2023; (82(4)):307-320 doi:10.1007/s00393-023-01345-2.
PMID: 37099180 - 61
French guidelines for the etiological workup of eosinophilia and the management of hypereosinophilic syndromes.
Groh M, Rohmer J, Etienne N, et al.
Orphanet journal of rare diseases 2023; (18(1)):100 doi:10.1186/s13023-023-02696-4.
PMID: 37122022 - 62
Pediatric hypereosinophilic syndrome associated with liver damage, portal vein, splenic vein and superior mesenteric vein thromboses: a case report.
Zheng HT, Xu Y, Yan XY, et al.
BMC pediatrics 2023; (23(1)):233 doi:10.1186/s12887-023-04014-0.
PMID: 37173706 - 63
Eosinophilic granulomatosis with polyangiitis - Advances in pathogenesis, diagnosis, and treatment.
Fijolek J, Radzikowska E
Frontiers in medicine 2023; (10()):1145257 doi:10.3389/fmed.2023.1145257.
PMID: 37215720 - 64
[Risk Factors and Prognosis of Cardiovascular Damage in Hypereosinophilia].
Zhang WJ, Zhang QK, Wei XF, et al.
Zhongguo shi yan xue ye xue za zhi 2023; (31(3)):810-815 doi:10.19746/j.cnki.issn.1009-2137.2023.03.028.
PMID: 37356944 - 65
HES and EGPA: Two Sides of the Same Coin.
Khoury P, Akuthota P, Kwon N, et al.
Mayo Clinic proceedings 2023; (98(7)):1054-1070 doi:10.1016/j.mayocp.2023.02.013.
PMID: 37419574 - 66
The portrait of a stranger: the hypereosinophilic syndrome with cardiac involvement.
Ivănescu AC, Petre A, Marincaș AS, et al.
Romanian journal of internal medicine = Revue roumaine de medecine interne 2023; (61(4)):222-227 doi:10.2478/rjim-2023-0016.
PMID: 37493620 - 67
Complement Factor I Gene Variant in an Atypical Hemolytic Uremic Syndrome Triggered by Hypereosinophilia Syndrome.
Banjongjit A, Kittanamongkolchai W, Kanjanabuch T
Nephron 2023; (147(11)):701-706 doi:10.1159/000531879.
PMID: 37611541 - 68
Eosinophilic Granulomatosis with Polyangiitis after mRNA-1273 SARS-CoV-2 Vaccine.
Mencarelli L, Moi L, Dewarrat N, et al.
Vaccines 2023; (11(8)) doi:10.3390/vaccines11081335.
PMID: 37631903 - 69
Coexistence of IgG4-related disease and ANCA-associated vasculitis: case report and review of the literature.
Korkmaz C, Yıldırım R, Dinler M, Cansu DU
Rheumatology international 2024; (44(3)):557-572 doi:10.1007/s00296-023-05419-x.
PMID: 37634133 - 70
FIP1L1-PDGFRA Clonal Hypereosinophilic Syndrome With Eosinophilic Myocarditis and Intracardiac Thrombus.
Locke M, Suen RM, Williamson AK, Nieto MJ
Cureus 2023; (15(8)):e43138 doi:10.7759/cureus.43138.
PMID: 37692703 - 71
Case report: Serious unexpected vascular events in two patients with lymphocytic variant hypereosinophilic syndrome.
Torcida N, Casalino G, Bondue A, et al.
Frontiers in cardiovascular medicine 2023; (10()):1256862 doi:10.3389/fcvm.2023.1256862.
PMID: 37829688 - 72
Eosinophilic myocarditis: systematic review.
Techasatian W, Gozun M, Vo K, et al.
Heart (British Cardiac Society) 2024; (110(10)):687-693 doi:10.1136/heartjnl-2023-323225.
PMID: 37963727 - 73
Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis.
Wechsler ME, Nair P, Terrier B, et al.
The New England journal of medicine 2024; (390(10)):911-921 doi:10.1056/NEJMoa2311155.
PMID: 38393328 - 74
Hypereosinophilic syndrome associated with multiple thromboses requiring ICU admission: A case report.
Ouanes I, Toumi S, Ben Cheikh Y, et al.
La Tunisie medicale 2023; (101(10)):783-786.
PMID: 38465762 - 75
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.
Shomali W, Gotlib J
American journal of hematology 2024; (99(5)):946-968 doi:10.1002/ajh.27287.
PMID: 38551368 - 76
Red flags for clinical suspicion of eosinophilic granulomatosis with polyangiitis (EGPA).
Solans-Laqué R, Rúa-Figueroa I, Blanco Aparicio M, et al.
European journal of internal medicine 2024; (128()):45-52 doi:10.1016/j.ejim.2024.06.008.
PMID: 38880725 - 77
[Eosinophilic granulomatosis with polyangiitis: a review article].
Schindler V, Venhoff N
Laryngo- rhino- otologie 2024; (103(10)):705-714 doi:10.1055/a-2214-1669.
PMID: 38964344 - 78
Literature review and case study of recurrent EPGA with elevated IgG4 and positive HBsAg successfully treated with rituximab.
Wang J, Wang J, Wang N, et al.
Renal failure 2024; (46(2)):2390569 doi:10.1080/0886022X.2024.2390569.
PMID: 39169678 - 79
Differential roles of eosinophils in cardiovascular disease.
Xu J, Guo J, Liu T, et al.
Nature reviews. Cardiology 2025; (22(3)):165-182 doi:10.1038/s41569-024-01071-5.
PMID: 39285242 - 80
Phase II trial of imatinib mesylate in patients with PDGFRA/B-negative hypereosinophilic syndrome.
Kim DH, Kim S, Park S, et al.
British journal of haematology 2024; (205(6)):2305-2314 doi:10.1111/bjh.19828.
PMID: 39389908 - 81
The Cleveland Clinic experience of eosinophilic myocarditis in the setting of hypereosinophilic syndrome: demographics, cardiac imaging, and outcomes.
Reeder M, Okushi Y, Lo Presti Vega S, et al.
Cardiovascular diagnosis and therapy 2024; (14(6)):1122-1133 doi:10.21037/cdt-24-347.
PMID: 39790190 - 82
Long-Term Safety and Efficacy of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis.
Wechsler ME, Silver J, Wolff G, et al.
Arthritis & rheumatology (Hoboken, N.J.) 2025; (77(8)):1052-1062 doi:10.1002/art.43146.
PMID: 40008472 - 83
Highlights from the plenary session: eosinophilic granulomatosis with polyangiitis and hypereosinophilic syndrome.
Holle JU, Vaglio A
Rheumatology (Oxford, England) 2025; (64(12 Suppl 2)):i92-i97 doi:10.1093/rheumatology/keae608.
PMID: 40071429 - 84
[Multidisciplinary expert consensus on diagnosis and treatment of eosinophilic granulomatosis with polyangiitis (2025 Edition)].
Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 2025; (48(5)):418-439 doi:10.3760/cma.j.cn112147-20250110-00027.
PMID: 40300867 - 85
Primary care physicians play a crucial role in diagnosing and managing rare eosinophilic diseases: HES and EGPA.
Shum M, Gewurz-Singer O, Silver J, Akuthota P
Frontiers in medicine 2025; (12()):1568770 doi:10.3389/fmed.2025.1568770.
PMID: 40630493 - 86
Microangiopathic Anemia.
Bommer M, Bloehdorn J
Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie 2025; (52(4)):259-270 doi:10.1159/000544724.
PMID: 40809448 - 87
Development and Validation of the FIP Score for the Screening of FIP1L1::PDGFRA-Associated Hypereosinophilic Syndrome.
Stammler R, Vallée A, Rohmer J, et al.
The journal of allergy and clinical immunology. In practice 2025; (13(11)):3066-3076.e2 doi:10.1016/j.jaip.2025.09.009.
PMID: 40992688 - 88
Organ-Restricted Hypereosinophilic Syndrome: A Case of Recurrent Hypereosinophilic Myopericarditis.
Alhajri N, Fadlelseed S, Abokhater N, et al.
JACC. Case reports 2025; (30(35)):105535 doi:10.1016/j.jaccas.2025.105535.
PMID: 41003456 - 89
Idiopathic hypereosinophilic syndrome complicated by computed tomography-negative cerebral infarction, strangulated intestinal obstruction, and hepatic portal venous gas: a case report of multi-system involvement.
Wei H, Ji C, Dong F, et al.
Quantitative imaging in medicine and surgery 2025; (15(11)):11630-11641 doi:10.21037/qims-2025-1070.
PMID: 41209273 - 90
Direct Fast Scarlet and Congo Red Staining in Identification of Eosinophils and Their Cell-Free Granules in Cardiac Tissue.
Kumaki T, Abe T, Kashimura T, et al.
International heart journal 2025; (66(6)):968-977 doi:10.1536/ihj.25-317.
PMID: 41320336 - 91
Updated treatment approaches for eosinophilic granulomatosis with polyangiitis: A systematic scoping review.
Shiomi M, Higuchi T, Akiyama M, et al.
Modern rheumatology 2026; (36(3)):415-421 doi:10.1093/mr/roaf126.
PMID: 41427848 - 92
Fulminant Idiopathic Hypereosinophilic Syndrome Presenting with Cardiac, Neurologic and Haematologic Involvement.
Ibrahim N, Batri A, Rivera RR, Zwein A
European journal of case reports in internal medicine 2025; (12(12)):006010 doi:10.12890/2025_006010.
PMID: 41536447 - 93
From hypereosinophilia to hypereosinophilic syndrome: real-world application of a two-tailed approach for HES diagnosis.
Nicola S, Borrelli R, Ridolfi I, et al.
Frontiers in immunology 2025; (16()):1735131 doi:10.3389/fimmu.2025.1735131.
PMID: 41567200 - 94
Persistent Hemorrhagic Lip Crusts as the Presenting Sign of Pediatric FIP1L1-PDGFRA-Positive Hypereosinophilic Syndrome: A Case Report and Review of the Literature.
Chiang YK, Ho YH
Pediatric dermatology 2026; (43(5)):1204-1208 doi:10.1111/pde.70233.
PMID: 42014566 - 95
MPRIP::PDGFRB fusion identified in a male patient with a myeloid/lymphoid neoplasm with eosinophilia.
Gao M, Bachiashvili K, Jamy O, et al.
Annals of hematology 2026; (105(5)).
PMID: 42043473 - 96
Hypereosinophilia of persistent/unknown cause: a bone marrow-based study integrating WHO-HAEM5 criteria and myeloid next-generation sequencing.
Eletrebi MM, Sanchez-Ramirez J, Abdalla A, Holman CJ
American journal of clinical pathology 2026; (165(5)) doi:10.1093/ajcp/aqag031.
PMID: 42106910 - 97
Organ Involvement and Constitutional Symptoms in Idiopathic Hypereosinophilic Syndrome: A 72-Patient Single-Centre Cohort.
Łacwik P, Kupryś-Lipińska I, Kucharczyk A, et al.
Journal of clinical medicine 2026; (15(14)) doi:10.3390/jcm15145569.
PMID: 42513483 - 98
Paraneoplastic Hypereosinophilia With Multisystem Involvement as an Atypical Presentation of Lung Adenocarcinoma.
Bravo S, Machado A, Medeiros P, et al.
Cureus 2026; (18(8)):e114369 doi:10.7759/cureus.114369.
PMID: 42598653 - 99
Idiopathic Hypereosinophilic Syndrome Presenting as Isolated Right Ventricular Endomyocardial Fibrosis With Intracavitary Thrombus: A Multimodality Imaging Case Report.
Loudiyi N, Malki M, Erregui H, et al.
Cureus 2026; (18(7)):e113350 doi:10.7759/cureus.113350.
PMID: 42639520 - 100
Mepolizumab reduces systemic corticosteroid-related toxicities and healthcare burden in patients with eosinophilic granulomatosis with polyangiitis and hypereosinophilic syndrome: a retrospective database study.
Pongdee T, Silver J, Deb A, et al.
Frontiers in allergy 2026; (7()):1843149 doi:10.3389/falgy.2026.1843149.
PMID: 42657158 - 101
Fulminant Eosinophilic Myocarditis in Steroid-Refractory Hypereosinophilic Syndrome: Navigating the Thrombotic Stage With Targeted Biologic Therapy.
Althobaiti M, Aldlgan D, Alfehaid L, et al.
JACC. Case reports 2026; (31(41)):109306 doi:10.1016/j.jaccas.2026.109306.
PMID: 42667290 - 102
Eosinophilia and Hypereosinophilia: A Practical Approach to Navigating a Broad Differential Diagnosis.
Wigerinck S, Vandenberghe P
European journal of haematology 2026; (117(6)):1485-1499 doi:10.1111/ejh.70299.
PMID: 42677931 - 103
Hypereosinophilic syndrome with Löffler endocarditis and multiple cerebral infarctions in a patient with a CLL-phenotype clonal B-cell population: a case report.
Wang H, Zhu F, Hu H
Frontiers in cardiovascular medicine 2026; (13()):1924869 doi:10.3389/fcvm.2026.1924869.
PMID: 42688267 - 104
Déjà vu.
Agrawal AO, Patankar AS, Samant R
BMJ case reports 2026; (19(9)) doi:10.1136/bcr-2026-273616.
PMID: 42749346 - 105
Study outcomes for eosinophilic granulomatosis with polyangiitis and hypereosinophilic syndrome: towards achieving treatment goals in clinical practice.
Cid MC, Hellmich B, Terrier B, et al.
Autoimmunity reviews 2026; 104207 doi:10.1016/j.autrev.2026.104207.
PMID: 42977011